Both hyperphosphatemia and increased blood calcitriol (active vitamin D) concentrations stimulate FGF‐23 production, which promotes urinary phosphorus excretion and decreases intestinal phosphorus reabsorption. Here, FGF23 is linked to hyperphosphatemia.